Cord Blood Stem Cell TransplantationPenile ImplantationFetal BloodBone Marrow TransplantationHematopoietic Stem Cell TransplantationBone MarrowTransplantation, HomologousStem CellsBone Marrow CellsTransplantation, AutologousStem Cell TransplantationHematopoietic Stem CellsMonocrotophosPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseUmbilical CordTransplantation ConditioningBlood BanksAntigens, CD34Bone and BonesCell DifferentiationWhole-Body IrradiationHematologic NeoplasmsTransplantation ChimeraGraft SurvivalTissue DonorsHematopoietic Stem Cell MobilizationLeukemiaBusulfanLiver TransplantationHistocompatibility TestingCells, CulturedAnemia, AplasticTreatment OutcomeHematopoiesisHistocompatibilityCombined Modality TherapyCyclophosphamideGranulocyte Colony-Stimulating FactorRecurrenceBone Marrow PurgingMice, SCIDBone Marrow DiseasesMesenchymal Stem Cell TransplantationTime FactorsRemission InductionKidney TransplantationMelphalanEmbryonic Stem CellsColony-Forming Units AssayMultiple MyelomaImmunosuppressive AgentsTransplantation, IsogeneicLeukemia, Myeloid, AcuteMesenchymal Stromal CellsMyeloablative AgonistsRetrospective StudiesMice, Inbred C57BLAdult Stem CellsFlow CytometryHematologic DiseasesCell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCell SeparationLeukapheresisLymphoma, Non-HodgkinLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaCell LineageTransplantation ImmunologySurvival AnalysisBone RemodelingHLA AntigensGraft vs Leukemia EffectHepatic Veno-Occlusive DiseaseBlood CellsDisease-Free SurvivalMyelodysplastic SyndromesSurvival RateBone Marrow NeoplasmsGraft RejectionT-LymphocytesBlood Cell CountLymphocyte DepletionAcute DiseaseImmunophenotypingImmunosuppressionRadiation ChimeraStem Cell FactorHeart TransplantationAntigens, CDPluripotent Stem CellsMice, Inbred NODLeukemia, MyeloidStem Cell NicheFollow-Up StudiesUmbilical VeinsInfant, NewbornChimerism